Josh O'HarraDeputy General Counsel at Eli Lilly and CompanySpeaker
Agenda Sessions
State of the Industry: CMS Updates and Regulatory Developments
, 8:45amView SessionApproaches and Considerations for Effectuating MFP
, 1:40pmView SessionCo-Chair's Opening Remarks
, 8:00amView Session